News

How Anorexics Control Appetite
Ryan Marotta, Assistant Editor
Anorexic patients may not experience the reward-based motivation for food that drives many individuals to eat, which would explain how they are able to control their appetite.
Krystle Vermes
The FDA has granted priority review status to Amgen’s supplemental New Drug Application for its carfilzomib (Kyprolis) cancer therapy.
Ryan Marotta, Assistant Editor
An oral formulation of deferasirox is approved for the treatment of chronic iron overload due to blood transfusions.
Ryan Marotta, Assistant Editor
Medtronic’s CoreValve System is now approved for first-of-its-kind “valve-in-valve” replacement.
Annual Meeting inspires pharmacists to work together to improve health care system for patients.
The association discourages pharmacist participation in executions on the basis that such activities are fundamentally contrary to the role of pharmacists as providers of health care.
Meghan Ross, Associate Editor
In his keynote address at the American Pharmacists Association’s general session, Daniel Kraft, MD, chairman of the medicine and neuroscience tracks for Singularity University, posited that it is time to think outside the box and reimagine health and pharmacy.
Ryan Marotta, Assistant Editor
Ferumoxytol (Feraheme) has been responsible for a number of serious reactions and deaths since its 2009 approval.

Association News

Annual Meeting inspires pharmacists to work together to improve health care system for patients.
The association discourages pharmacist participation in executions on the basis that such activities are fundamentally contrary to the role of pharmacists as providers of health care.
The completed endowment included a $37,000 pledge from the National Association of Nuclear Pharmacies.
Registration is now open for first US session of patient care skills development program.
More than 350 pharmacy advocates from 44 states met with members of Congress during NACDS RxIMPACT Day on Capitol Hill.

Pharmacy Market News

Collaboration with Aduro is focused on discovery and development of next generation cancer immunotherapies targeting the STING signaling pathway.
Expected to strengthen Teva's core CNS franchise, establish Teva's leadership in underserved movement disorders space, provide compelling new treatment options for patients in need, and enhance Teva's long-term revenue and earnings growth.
The collaboration aims to educate adults with diabetes about their increased risk for potentially serious health problems, including pneumococcal pneumonia, influenza, and hepatitis B.

Strategic Alliance Partner News

$AD300x250BB$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$